As shown in Figure 4, IBC reduced mRNA levels of SREBP1c, adiponectin, ACC-1, and FAS to inhibit adipogenesis, suggesting its potential anti-obesity effect. The gene discussed is FAS; the disease is obesity due to melanocortin 4 receptor deficiency.